Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.1K Sell
11,455
-18,455
-62% -$66.1K ﹤0.01% 1211
2026
Q1
$99.9K Sell
29,910
-1,796
-6% -$5.96K ﹤0.01% 1041
2025
Q4
$99.6K Sell
31,706
-23,114
-42% -$92K ﹤0.01% 1139
2025
Q3
$211K Buy
+54,820
New +$274K ﹤0.01% 1029
2023
Q4
Sell
-8,640
Closed -$195K 970
2023
Q3
$195K Sell
8,640
-2,078
-19% -$58.9K ﹤0.01% 860
2023
Q2
$343K Buy
+10,718
New +$343K 0.01% 642
2022
Q1
Sell
-8,827
Closed -$557K 879
2021
Q4
$557K Buy
+8,827
New +$696K 0.02% 153

Other funds holding AGEN

Graham Capital Management's AGEN Position: Q2 2026 in Review

Graham Capital Management reduced its Agenus (AGEN) stake by 62% in Q2 2026, selling an estimated $66.1K and leaving 11,455 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

Graham Capital Management first reported a position in AGEN in Q4 2021 and has held it in 7 quarters since. The position peaked at $557K in Q4 2021. 103 funds tracked by Wall St. Rank hold AGEN as of Q2 2026.

  • Graham Capital Management held 11,455 shares of Agenus worth $35.1K as of Q2 2026.
  • Graham Capital Management sold 18,455 Agenus shares in Q2 2026, an estimated $66.1K.
  • Agenus made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1211 holding.
  • Graham Capital Management first reported a position in Agenus in Q4 2021 and has held it in 7 quarters since.
  • Graham Capital Management's Agenus position peaked at $557K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Agenus as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.